Table 4.
Level of asthma control among adults with current asthma | ||||||||
---|---|---|---|---|---|---|---|---|
|
||||||||
Controlled asthma | Uncontrolled asthma | |||||||
|
|
|||||||
Survey respondents | Well-controlled asthma | Not-well-controlled | Very-poorly-controlled | |||||
|
|
|
|
|||||
Characteristics | No.c | %d (95% CId) | No.c | %d (95% CId) | No.c | %d (95% CId) | No.c | %d (95% CId) |
Total | 52 210 | 24 378 | 50.0 (48.9–51.0) | 13 395 | 25.9 (25.0–26.8) | 14 437 | 24.1 (23.3–25.0) | |
Sexe | ||||||||
Male | 13 760 | 36.9 (35.9–38.0) | 6665 | 53.1 (51.0–55.1) | 3286 | 24.3 (22.6–26.0) | 3809 | 22.7 (21.1–24.3) |
Female | 38 450 | 63.1(62.0–64.1) | 17 713 | 48.2 (47.0–49.3) | 10 109 | 26.9 (25.9–27.9) | 10 628 | 25.0 (24.0–25.9) |
Age, year rangee | ||||||||
18–34 | 5617 | 30.7 (29.5–31.9) | 3220 | 56.9 (54.3–59.4) | 1469 | 26.8 (24.6–29.2) | 928 | 16.4 (14.5–18.4) |
35–44 | 6821 | 18.5 (17.8–19.3) | 3682 | 52.7 (50.3–55.0) | 1748 | 26.8 (24.7–29.0) | 1391 | 20.5 (18.8–22.4) |
45–54 | 11 416 | 19.6 (18.9–20.3) | 5253 | 47.0 (45.3–48.8) | 2890 | 24.8 (23.4–26.4) | 3273 | 28.1 (26.6–29.8) |
55–64 | 13 509 | 15.9 (15.4–16.5) | 5982 | 44.5 (42.8–46.1) | 3439 | 25.1 (23.7–26.5) | 4088 | 30.5 (29.0–32.0) |
65+ | 14 643 | 15.3 (14.8–15.8) | 6148 | 42.5 (41.0–44.1) | 3792 | 25.4 (24.1–26.7) | 4703 | 32.1 (30.7–33.6) |
Race/Ethnicitye,f | ||||||||
White | 42 517 | 74.6 (73.6–75.6) | 20 052 | 50.5 (49.3–51.6) | 11 091 | 26.9 (25.9–27.9) | 11 374 | 22.7 (21.8–23.5) |
Black | 3236 | 9.7 (9.0–10.3) | 1414 | 47.7 (44.1–51.4) | 774 | 24.5 (21.4–27.7) | 1048 | 27.8 (24.7–31.1) |
Hispanic | 2342 | 9.0 (8.3–9.7) | 1094 | 49.8 (45.4–54.1) | 566 | 23.8 (20.3–27.8) | 682 | 26.4 (22.7–30.5) |
Other race | 3656 | 6.7 (6.2–7.4) | 1606 | 48.7 (44.1–53.4) | 852 | 19.9 (16.9–23.3) | 1198 | 31.4 (27.6–35.5) |
Education levele | ||||||||
High School graduate or less | 19 215 | 36.4 (35.4–37.4) | 7583 | 41.6 (39.8–43.4) | 4692 | 24.8 (23.2–26.4) | 6940 | 33.7 (32.0–35.3) |
Some college | 15 486 | 28.5 (27.6–29.4) | 6937 | 48.7 (46.8–50.5) | 4119 | 27.7 (26.0–29.4) | 4430 | 23.7 (22.3–25.1) |
College 4 or more years | 17 452 | 35.2 (34.2–36.1) | 9843 | 59.8 (58.1–61.4) | 4570 | 25.7 (24.3–27.2) | 3039 | 14.5 (13.5–15.7) |
Household incomee | ||||||||
<$15 000 | 8146 | 14.7 (14.0–15.5) | 2509 | 33.8 (31.3–36.5) | 1885 | 24.5 (22.0–27.2) | 3752 | 41.6 (39.0–44.3) |
$15 000–$24 999 | 8967 | 16.7 (15.8–17.5) | 3389 | 39.4 (36.6–42.3) | 2351 | 25.3 (23.1–27.7) | 3227 | 35.3 (32.7–38.0) |
$25 000–$49 999 | 12 351 | 23.8 (23.0–24.7) | 5883 | 48.5 (46.5–50.5) | 3323 | 27.5 (25.7–29.4) | 3145 | 24.0 (22.4–25.7) |
$50 000–$74 999 | 7143 | 15.1 (14.4–15.8) | 3879 | 55.3 (52.7–57.8) | 1915 | 27.7 (25.4–30.2) | 1349 | 17.0 (15.3–18.8) |
≥$75 000 | 10 428 | 29.7 (28.7–30.7) | 6332 | 61.9 (59.9–63.9) | 2644 | 25.2 (23.4–27.0) | 1452 | 12.9 (11.8–14.2) |
Health care coverage in past 12 monthse | ||||||||
No insurance | 4616 | 13.1 (12.3–14.0) | 1910 | 45.3 (41.8–48.9) | 1227 | 27.0 (24.0–30.2) | 1479 | 27.7 (24.8–30.7) |
Partial year coverage | 2515 | 6.5 (6.0–7.1) | 1004 | 42.7 (38.4–47.2) | 607 | 26.0 (22.1–30.3) | 904 | 31.3 (27.3–35.7) |
Full year coverage | 44 876 | 80.3 (79.4–81.3) | 21 324 | 51.2 (50.1–52.3) | 11 534 | 25.8 (24.8–26.8) | 12 018 | 23.0 (22.1–23.9) |
Cost as barriere,g | ||||||||
Yes | 9443 | 20.6 (19.7–21.4) | 2644 | 30.3 (28.1–32.6) | 2643 | 29.7 (27.6–32.0) | 4156 | 40.0 (37.7–42.3) |
No | 42 572 | 79.4 (78.6–80.3) | 21 636 | 55.0 (53.9–56.1) | 10 701 | 25.0 (24.0–26.0) | 10 235 | 20.0 (19.2–20.9) |
Long-term control medicationse | ||||||||
Yes | 24 786 | 41.5 (40.5–42.5) | 8698 | 35.6 (34.3–37.0) | 7346 | 31.4 (30.0–32.8) | 8742 | 33.0 (31.7–34.4) |
No | 27 424 | 58.5 (57.5–59.5) | 15680 | 60.2 (58.8–61.5) | 6049 | 22.1 (20.9–23.2) | 5695 | 17.8 (16.8–18.8) |
Anyone Smoked inside homee,h | ||||||||
Yes | 8866 | 18.2 (17.4–19.1) | 2714 | 35.3 (32.7–37.9) | 2233 | 26.5 (24.3–28.9) | 3919 | 38.2 (35.8–40.7) |
No | 43 243 | 81.8 (81.0–82.6) | 21 603 | 53.2 (52.1–54.3) | 11 145 | 25.8 (24.8–26.8) | 10 495 | 21.0 (20.1–21.9) |
Smoking statuse | ||||||||
Current smoker | 9510 | 19.5 (18.7–20.3) | 2945 | 35.2 (33.0–37.6) | 2440 | 27.4 (25.2–29.6) | 4125 | 37.4 (35.2–39.6) |
Former smoker | 17 622 | 27.1 (26.3–28.0) | 7690 | 46.6 (44.9–48.4) | 4613 | 25.2 (23.8–26.7) | 5319 | 28.2 (26.7–29.7) |
Non-smoker | 24 858 | 53.4 (52.4–54.4) | 13 634 | 57.0 (55.5–58.5) | 6293 | 25.8 (24.5–27.1) | 4931 | 17.2 (16.2–18.3) |
Smoking status & SHSe | ||||||||
Current smoker &SHS | 6353 | 11.9 (11.2–12.6) | 1716 | 31.2 (28.2–34.3) | 1618 | 27.3 (24.5–30.2) | 3019 | 41.5 (38.7–44.5) |
Current smoker &No SHS | 3138 | 7.6 (7.1–8.2) | 1219 | 41.4 (37.7–45.2) | 817 | 27.7 (24.3–31.3) | 1102 | 31.0 (27.5–34.7) |
Former smoker &SHS | 1341 | 2.6 (2.3–2.9) | 461 | 34.6 (29.2–40.4) | 325 | 25.9 (20.1–32.7) | 555 | 39.5 (33.8–45.7) |
Former smoker &No SHS | 16 247 | 24.6 (23.8–25.4) | 7210 | 47.9 (46.0–49.7) | 4285 | 25.2 (23.7–26.7) | 4752 | 27.0 (25.5–28.5) |
Non-smoker & SHS | 1143 | 3.8 (3.3–4.3) | 527 | 48.7 (41.9–55.6) | 281 | 24.7 (20.0–30.1) | 335 | 26.6 (21.1–32.9) |
Non-smoker &No SHS | 23 667 | 49.6 (48.6–50.7) | 13 075 | 57.6 (56.1–59.1) | 6003 | 25.9 (24.6–27.3) | 4589 | 16.5 (15.5–17.6) |
If pets allowed in bedroome | ||||||||
Pets allowed | 22 711 | 44.3 (43.3–45.3) | 10 565 | 49.2 (47.7–50.8) | 6069 | 27.1 (25.7–28.5) | 6077 | 23.7 (22.4–25.0) |
Pets Not allowed | 6950 | 15.2 (14.4–16.0) | 3042 | 46.5 (43.7–49.4) | 1820 | 27.0 (24.5–29.6) | 2088 | 26.5 (24.2–29.0) |
No pets | 22 542 | 40.5 (39.5–41.5) | 10 768 | 52.1 (50.5–53.6) | 5506 | 24.3 (22.9–25.7) | 6268 | 23.7 (22.5–24.9) |
Saw cockroach inside home past 30 de | ||||||||
Yes | 4098 | 9.7 (9.1–10.3) | 1800 | 43.7 (40.2–47.2) | 984 | 26.8 (23.6–30.2) | 1314 | 29.5 (26.7–32.5) |
No | 47 972 | 90.3 (89.7–90.9) | 22 497 | 50.6 (49.5–51.7) | 12 383 | 25.8 (24.9–26.8) | 13 092 | 23.5 (22.7–24.4) |
Saw or smelled mold past 30 de | ||||||||
Yes | 6017 | 11.6 (11.0–12.2) | 2335 | 41.5 (38.7–44.5) | 1692 | 29.8 (27.2–32.6) | 1990 | 28.7 (26.3–31.1) |
No | 45 844 | 88.4 (87.8–89.0) | 21 899 | 51.1 (50.0–52.2) | 11 640 | 25.4 (24.5–26.4) | 12 305 | 23.5 (22.6–24.4) |
Body mass indexe | ||||||||
Obese | 20 714 | 39.4 (38.4–40.4) | 8874 | 45.2 (43.5–46.9) | 5401 | 26.1 (24.7–27.5) | 6439 | 28.8 (27.3–30.2) |
Non-obese | 29 539 | 60.6 (59.6–61.6) | 14 593 | 53.4 (52.0–54.7) | 7495 | 25.8 (24.6–27.0) | 7451 | 20.9 (19.9–21.9) |
COPDe,i | ||||||||
Yes | 21 539 | 34.6 (33.7–35.5) | 6868 | 33.7 (32.1–35.2) | 5619 | 27.2 (25.8–28.7) | 9052 | 39.2 (37.7–40.7) |
No | 30 480 | 65.4 (64.5–66.4) | 17 417 | 58.6 (57.2–59.9) | 7724 | 25.3 (24.1–26.5) | 5339 | 16.2 (15.2–17.2) |
Depressione | ||||||||
Yes | 19 734 | 34.7 (33.7–35.6) | 7617 | 41.1 (39.4–42.7) | 5230 | 26.4 (25.0–27.9) | 6887 | 32.6 (31.0–34.1) |
No | 32 133 | 65.3 (64.4–66.3) | 16 596 | 54.6 (53.3–55.9) | 8077 | 25.8 (24.6–26.9) | 7460 | 19.6 (18.7–20.6) |
CI, confidence interval; SHS, secondhand smoke exposure; COPD, chronic obstructive pulmonary disease.
Defined as the most impaired level from the one or more individual elements (i.e. daytime and night time symptoms in past 30 d and rescue medication use in past 3 months).
Persons who answered “yes” to the question “Have you ever been told by a doctor or other health professional that you had asthma?” or “Has a doctor.”
Unweighted pooled sample size, 2006–2010. Due to item non-response, individual characteristic categories may not sum to total.
Weighted prevalence and 95% confidence interval.
p values were <0.001 for the Chi-square test of association between asthma controlled status and all selected variables in the table.
Race categories “white, non-Hispanic”, “black, non-Hispanic”, include persons who indicated only a single race group. “Other races, non-Hispanic” insurance includes Asian, American Indian Alaskan Native, Native Hawaiian and Other Pacific Islander, persons reporting more than one race, and persons reporting their race as something other than those listed here.
Cost as barrier for primary care doctor, specialist, and medicine.
Indicates secondhand smoke exposure (SHS).
Combined responses to questions for COPD, emphysema, and chronic bronchitis.